Supreme Court Ruling Could Stifle Open Debate In Journals

Editors fear that a recent redefinition of `protected speech' could force them to stifle controversy in order to avoid lawsuits The freedom of scientists to candidly criticize their colleagues' theories in professional journals could be sharply curtailed by a Supreme Court ruling on libel handed down this past summer. Journal editors currently defending themselves in court against charges that their publications have been a party to a malicious attack fear that the high court decision could ha

Written byCathy Sears
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share


Editors fear that a recent redefinition of `protected speech' could force them to stifle controversy in order to avoid lawsuits
The freedom of scientists to candidly criticize their colleagues' theories in professional journals could be sharply curtailed by a Supreme Court ruling on libel handed down this past summer. Journal editors currently defending themselves in court against charges that their publications have been a party to a malicious attack fear that the high court decision could have a damaging effect on their cases.

"People in Eastern Europe can now speak freely, but here, if you have millions, you can muzzle free speech," says Jan Moor-Jankowski, professor of medical research at New York University School of Medicine and cofounder and editor of the Journal of Medical Primatology. "That's the chilling effect of this Supreme Court ruling."

Moor-Jankowski and other editors have long operated under the assumption, based on prior court decisions, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies